Tailored activity plans could boost heart health in kids with congenital heart disease

NCT ID NCT06945003

Completed Disease control Sponsor: University of Ulster Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests whether a personalized physical activity plan can help children aged 5–18 with congenital heart disease increase their exercise capacity and daily activity levels. The plan is designed with input from parents, teachers, and a pediatric cardiologist to address safety concerns. Participants follow the plan at home for 12 weeks, with follow-ups at 3 and 6 months. The goal is to improve heart and lung function and help more children meet recommended physical activity guidelines.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: individualized physical activity plan (SHAPE)
What this could lead to: If effective, this plan could help children with congenital heart disease safely increase their exercise capacity and meet recommended physical activity guidelines, improving their heart health and quality of life.
What could go wrong: This is a small, early-stage trial with 60 participants, so results may not apply to all children with congenital heart disease. The plan relies on family and school cooperation, which may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congenital heart disease Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONGENITAL HEART DISEASE

Contacts and locations

Locations

Royal Belfast Hospital for Sick Children

Belfast, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.